jRCT1080223310未知N/a
Administration study to healthy adult male as part of reserch toward the development of detection method for testosterone doping
试验速览
- 阶段
- N/a
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20age old over 至 35age old under(—)
- 性别
- Male
入选标准
- •Age:20 or more years old, less than 35 years old.
- •BMI The weight (kg) / height (m) 2 :18.5 or more and less than 25.0(at the time of a prior inspection).
- •There is consent to clinical test participation.
排除标准
- •1.Hypersensitivity to sesami oil and drugs,
- •2.A history of alcohol or drug addiction,
- •3.Under the medical treatment or it may treatof a certain disease,
- •4.Ethical or OTC pharmaceuticals administered within two weeks before scheduled administation of the study drug, Supplement,
- •grapefruit or its products, or foods cotaing Western St. John's comsumed within one week before scheduled administation of the study drug,
- •5.Not less than 200mL of blood is collected within 30 days or not less than 400mL of blood is collected within 90 days before scheduled
- •administation of the study drug,
- •6.Weight : less than 50kg(at the time of a prior inspection),
- •7.A person shall not have a schedule of consultation of another hospital until this administration study,
- •8.A person shall not have possibility of prostatic hypertrophy, heart disease, kidny disease or medical histrory,
- •9.A person judged unfit of this study by responsible doctor
研究者
相似试验
未知
Unknown
Administration study to healthy adult male as part of reserch toward the development of detection method for testosterone doping-JPRN-jRCT1080223310SI Medience Corporation10
未知
Unknown
Administration study to healthy adult male as part of reserach toward the development of detection method for testosterone doping-JPRN-jRCT1080222855SI Medience Corporation8
已完成
2 期
A study in healthy male adult participants to assess how much test medicine (SAR443820) is taken up, broken down and removed by the body when given in a liquid form by mouth.2022-502534-23-00Sanofi-Aventis Research & Development6
已完成
1 期
A phase I study to determine the tolerability and safety of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).To promote pain relief in healthy volunteers.Anaesthesiology - Pain managementACTRN12609000836235Phosphagenics Limited44
已完成
不适用
A single-site, open-label study in healthy male subjects to compare rotigotine saliva and plasma concentrations in steady-state after multiple-dose application of rotigotine transdermal patchrestless legs10028037Parkinson's DiseaseNL-OMON35531CB Pharma14
